PPAR-γ Agonist Alleviates Liver and Spleen Pathology via Inducing Treg Cells during Schistosoma japonicum Infection

Joint Authors

Zhu, Yuxiao
Ni, Yangyue
Liu, Ran
Yang, Bingya
Song, Jingwei
Sun, Hongzhi
Xu, Zhipeng
Hou, Min
Ji, Minjun

Source

Journal of Immunology Research

Issue

Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-11, 11 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2018-07-17

Country of Publication

Egypt

No. of Pages

11

Main Subjects

Biology

Abstract EN

Background.

Peroxisome proliferator-activated receptor- (PPAR-) γ plays critical roles in human metabolic disorders and has recently been implicated as a regulator of cellular proliferation and inflammatory responses.

Regulatory T cells (Tregs), which express high levels of PPAR-γ protein, have the ability to maintain immune tolerance to self-antigens and regulate immune response to Schistosoma infection.

However, mechanisms involved in the resolution of these responses are elusive.

Methods.

Liver and spleen tissue samples in Schistosoma japonicum-infected mice after administration of pioglitazone (a PPAR-γ agonist) were collected.

The hepatic and splenic pathologies were detected by H&E and Masson staining.

The percentages of Th1/2 and Treg cells in the liver and spleen of each mouse were determined using flow cytometry.

Levels of gene expression of PPAR-γ and Foxp3 in tissues or cells were determined using real-time PCR (RT-PCR).

Macrophages were treated with pioglitazone in vitro or cocultured with normal purified CD4+ T cells for detecting Treg cells by flow cytometry.

The interactions of PPAR-γ with Foxp3 in CD4+ T cells were detected by coimmunoprecipitation.

Results.

Administration of pioglitazone resulted in the prevention of the development of hepatic and splenic pathologies.

Activation of PPAR-γ by pioglitazone resulted in increased percentages of CD4+CD25+Foxp3+ Treg cells and decreased percentages of CD3+CD4+IFN-γ+ and CD3+CD4+IL-4+ cells in the liver and spleen of Schistosoma japonicum-infected mice.

In addition, the PPAR-γ agonist can induce Treg cells in vitro directly or by modulating the macrophage’s function indirectly.

Furthermore, through interaction with Foxp3 in CD4+ T cells, the PPAR-γ agonist can promote the expression of Foxp3; however, the inhibitor of PPAR-γ weakened the expression of Foxp3 by modifying the coexpression of Foxp3 and PPAR-γ.

Conclusions.

Our study reveals a previously unrecognized role for PPAR-γ/Foxp3 signaling in regulating the immunopathology that occurs during Schistosoma infection through induction of Treg cells.

American Psychological Association (APA)

Zhu, Yuxiao& Ni, Yangyue& Liu, Ran& Hou, Min& Yang, Bingya& Song, Jingwei…[et al.]. 2018. PPAR-γ Agonist Alleviates Liver and Spleen Pathology via Inducing Treg Cells during Schistosoma japonicum Infection. Journal of Immunology Research،Vol. 2018, no. 2018, pp.1-11.
https://search.emarefa.net/detail/BIM-1192772

Modern Language Association (MLA)

Zhu, Yuxiao…[et al.]. PPAR-γ Agonist Alleviates Liver and Spleen Pathology via Inducing Treg Cells during Schistosoma japonicum Infection. Journal of Immunology Research No. 2018 (2018), pp.1-11.
https://search.emarefa.net/detail/BIM-1192772

American Medical Association (AMA)

Zhu, Yuxiao& Ni, Yangyue& Liu, Ran& Hou, Min& Yang, Bingya& Song, Jingwei…[et al.]. PPAR-γ Agonist Alleviates Liver and Spleen Pathology via Inducing Treg Cells during Schistosoma japonicum Infection. Journal of Immunology Research. 2018. Vol. 2018, no. 2018, pp.1-11.
https://search.emarefa.net/detail/BIM-1192772

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1192772